Activation of SphK1 by K6PC-5 Inhibits Oxygen-Glucose Deprivation/Reoxygenation-Induced Myocardial Cell Death

DNA and Cell Biology

Volumn 34, Issue 11, 2015, Pages 669-676

  Shao, Jun Jie ^a   Peng, Yi ^b   Wang, Li Ming ^a   Wang, Jian Kai ^a   Chen, Xin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B 5354C; CERAMIDE; CYCLOPHILIN D; ENZYME ACTIVATOR; GLUCOSE; N (1,3 DIHYDROXYISOPROPYL) 2 HEXYL 3 OXO DECANAMIDE; OXYGEN; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1; UNCLASSIFIED DRUG; AMIDE; N-(1,3-DIHYDROXYISOPROPYL)-2-HEXYL-3-OXODECANAMIDE; PHOSPHOTRANSFERASE; SPHINGOSINE KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; HEART MUSCLE CELL; INTRACELLULAR SIGNALING; ISCHEMIC HEART DISEASE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOXYGENATION; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE CELL; CELL CULTURE; CELL DEATH; CELL LINE; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; RAT;

AMIDES; ANIMALS; CELL DEATH; CELL LINE; CELLS, CULTURED; CERAMIDES; ENZYME ACTIVATION; GLUCOSE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE, INBRED C57BL; MYOCYTES, CARDIAC; OXYGEN; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RATS;

EID: 84946740139     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2015.2959     Document Type: Article

References (27)

1. Baumann, K. (2012). Cell death: multitasking p53 promotes necrosis. Nat Rev Mol Cell Biol 13, 480-481.
2. Chen, M. B., et al. (2011). Activation of AMP-activated protein kinase contributes to doxorubicin-induced cell death and apoptosis in cultured myocardial H9c2 cells. Cell Biochem Biophys 60, 311-322.
3. Chen, Z., et al. (2013). TAK1activates AMPK-dependent cell death pathway in hydrogen peroxide-treated cardiomyocytes, inhibited by heat shock protein-70. Mol Cell Biochem 377, 35-44.
4. Chiba, Y., et al. (2010). SKI-II, an inhibitor of sphingosine kinase, ameliorates antigen-induced bronchial smooth muscle hyperresponsiveness, but not airway inflammation, in mice. J Pharmacol Sci 114, 304-310.
5. Ekhterae, D., et al. (1999). ARC inhibits cytochrome c release from mitochondria and protects against hypoxia-induced apoptosis in heart-derived H9c2 cells. Circ Res 85, e70-e77.
6. Hong, J. H., et al. (2008). K6PC-5, a direct activator of sphingosine kinase 1, promotes epidermal differentiation through intracellular Ca2+ signaling. J Invest Dermatol 128, 2166-2178.
7. Ito, H., et al. (1991). Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 69, 209-215.
8. Ji, F., et al. (2015). K6PC-5, a novel sphingosine kinase 1 (SphK1) activator, alleviates dexamethasone-induced damages to osteoblasts through activating SphK1-Akt signaling. Biochem Biophys Res Commun 458, 568-575.
9. Jin, Z. Q., et al. (2002). Cardioprotectionmediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts. Am J Physiol Heart Circ Physiol 282, H1970-H1977.
10. Karch, J., et al. (2012). Is p53 the long-sought molecular trigger for cyclophilin D-regulated mitochondrial permeability transition pore formation and necrosis? Circ Res 111, 1258-1260.
11. Karliner, J. S., et al. (2001). The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J Mol Cell Cardiol 33, 1713-1717.
12. Kono, K., et al. (2002). Inhibition of recombinant sphingosine kinases by novel inhibitors of microbial origin, F-12509A and B-5354c. J Antibiot (Tokyo) 55, 99-103.
13. Kwon, Y. B., et al. (2007). Novel synthetic ceramide derivatives increase intracellular calcium levels and promote epidermal keratinocyte differentiation. J Lipid Res 48, 1936-1943.
14. Li, P. H., et al. (2014). A sphingosine kinase-1 inhibitor, SKI-II, induces growth inhibition and apoptosis in human gastric cancer cells. Asian Pac J Cancer Prev 15, 10381-10385.
15. Marambio, P., et al. (2010). Glucose deprivation causes oxidative stress and stimulates aggresome formation and autophagy in cultured cardiac myocytes. Biochim Biophys Acta 1802, 509-518.
16. Mullen, T. D., et al. (2012). Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death. Anticancer Agents Med Chem12, 340-363.
17. Nabel, E. G., et al. (2012). A tale of coronary artery disease and myocardial infarction. N Engl J Med 366, 54-63.
18. Persky, A. M., et al. (2000). Protective effect of estrogens against oxidative damage to heart and skeletal muscle in vivo and in vitro. Proc Soc Exp Biol Med 223, 59-66.
19. Shida, D., et al. (2008). Targeting SphK1 as a new strategy against cancer. Curr Drug Targets 9, 662-673.
20. Simmons, W. W., et al. (1996). Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-arginine transport and no production by CAT-1, CAT-2A, and CAT-2B. J Biol Chem 271, 11694-11702.
21. Steptoe, A., et al. (2012). Stress and cardiovascular disease. Nat Rev Cardiol 9, 360-370.
22. Vadas, M., et al. (2008). The role of sphingosine kinase 1 in cancer: oncogene or non-oncogene addiction? Biochim Biophys Acta 1781, 442-447.
23. Vaseva, A. V., et al. (2012). p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 149, 1536-1548.
24. White, S. M., et al. (2004). Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am J Physiol Heart Circ Physiol 286, H823-H829.
25. Yao, C., et al. (2012). Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro. Mol Oncol 6, 392-404.
26. Zhen, Y. F., et al. (2014). P53 dependent mitochondrial permeability transition pore opening is required for dexamethasoneinduced death of osteoblasts. J Cell Physiol 229, 1475-1483.
27. Zheng, K., et al. (2014). Salidroside inhibits oxygen glucose deprivation (OGD)/re-oxygenation-induced H9c2 cell necrosis through activating ofAkt-Nrf2 signaling. BiochemBiophys Res Commun 451, 79-85.